Original Research
Published on 28 Oct 2024
Patients with dementia: prevalence and type of drug–drug interactions
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472932
- 768 views
Type at least 3 characters
2,285 articles
Articles
Original Research
Published on 25 Oct 2024
Dopamine internalization via Uptake2 and stimulation of intracellular D5-receptor-dependent calcium mobilization and CDP-diacylglycerol signaling
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422998
- 541 views
Systematic Review
Published on 23 Oct 2024
Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1481617
- 1,696 views
Original Research
Published on 22 Oct 2024
Green rush and red warnings: Retrospective chart review of adverse events of interactions between cannabinoids and psychotropic drugs
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500312
- 1,301 views
Original Research
Published on 17 Oct 2024
Precuneal hyperperfusion in patients with attention-deficit/hyperactivity disorder-comorbid nociplastic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480546
- 2,039 views
Review
Published on 17 Oct 2024
The role of exercise-related FNDC5/irisin in depression
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1461995
- 1,165 views
Systematic Review
Published on 17 Oct 2024
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411631
- 1,638 views
Original Research
Published on 16 Oct 2024
Decreasing brain activity caused by acute administration of ketamine and alcohol – A randomized, controlled, observer-blinded experimental study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1456009
- 566 views
Editorial
Published on 14 Oct 2024
Editorial: New players on the monoaminergic field: relevance to the mental disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1504261
- 484 views
Original Research
Published on 14 Oct 2024
Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472468
- 661 views
Brief Research Report
Published on 10 Oct 2024
Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413812
- 1,623 views
Original Research
Published on 09 Oct 2024
Fentanyl enhances immune cell response through TLR4/MD-2 complex
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468644
- 825 views
Original Research
Published on 07 Oct 2024
Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445509
- 776 views
Editorial
Published on 03 Oct 2024
Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499072
- 580 views
Mini Review
Published on 02 Oct 2024
Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491563
- 679 views
Brief Research Report
Published on 02 Oct 2024
Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466351
- 580 views